牵引辅助与传统内镜黏膜下剥离术治疗大型食管癌的多中心随机对照试验
这项在日本7家机构开展的优势性随机III期试验纳入肿瘤直径>20 mm的大型食管癌患者,比较传统ESD与牵引辅助ESD(TA-ESD)。TA-ESD组手术时长显著短于传统ESD组(44.5分钟 vs 60.5分钟,P < .001),TA-ESD组未观察到不良事件,两组水平切缘阳性率无显著差异(10.3% vs 6.9%,P = .484)。
要点
- TA-ESD组手术时长44.5分钟,显著短于传统ESD组的60.5分钟(P < .001)。
- TA-ESD组未观察到不良事件,传统ESD组有1例因严重穿孔中止手术。
- 两组水平切缘阳性率无显著差异(传统ESD 10.3% vs TA-ESD 6.9%,P = .484)。
核心结论
- TA-ESD在手术时长方面优于传统ESD,且未发生不良事件。
- 原文结论认为TA-ESD应被视为大型食管癌的首选术式。
研究设计与样本
- 优势性、随机、III期试验,在日本7家机构开展。
- 纳入肿瘤直径>20 mm的大型食管癌患者,随机分配接受传统ESD或TA-ESD。
- 传统ESD组1例因严重穿孔中止手术,最终每组116例纳入主要分析。
- 主要终点为ESD手术时长。
主要发现
- TA-ESD组手术时长为44.5分钟,传统ESD组为60.5分钟,TA-ESD组显著更短(P < .001)。
- TA-ESD组未观察到不良事件。
- 水平切缘阳性率传统ESD组为10.3%,TA-ESD组为6.9%,两组无显著差异(P = .484)。
关键数值与推荐
- 大型食管癌定义为肿瘤直径>20 mm。
- 主要终点ESD手术时长:TA-ESD组44.5分钟 vs 传统ESD组60.5分钟(P < .001)。
- 水平切缘阳性率:传统ESD组10.3% vs TA-ESD组6.9%(P = .484)。
临床怎么用
- 原文结论认为TA-ESD应被视为大型食管癌的首选术式。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Endoscopic submucosal dissection (ESD) is widely used as a minimally invasive treatment for large esophageal cancers, but prolonged procedure duration and life-threatening adverse events remain matters of concern. We aimed to determine whether traction-assisted ESD (TA-ESD) is superior to conventional ESD in terms of technical outcomes. METHODS: A superiority, randomized, phase III trial was conducted at 7 institutions across Japan. Patients with large esophageal cancer (defined as tumor diameter >20 mm) were eligible for this study. Enrolled patients were randomly assigned to undergo conventional ESD or TA-ESD. The primary endpoint was ESD procedure duration. RESULTS: Two hundred forty-one patients were recruited and randomized. On applying exclusion criteria, 117 and 116 patients who underwent conventional ESD and TA-ESD, respectively, were included in the baseline analysis. In 1 patient, conventional ESD was discontinued because of severe perforation. Thus, the final analysis included 116 patients per group (primary analysis). The ESD procedure duration was significantly shorter for TA-ESD than for conventional ESD (44.5 minutes vs 60.5 minutes, respectively; P < .001). Moreover, no adverse events were noted in the TA-ESD group. The rate of horizontal margin involvement did not differ between the groups (10.3% vs 6.9% for conventional ESD and TA-ESD, respectively; P = .484). CONCLUSIONS: TA-ESD was superior to conventional ESD in terms of procedure duration and was not associated with any adverse events. TA-ESD should be considered the procedure of choice for large esophageal cancers. (Clinical trial registration number: UMIN000024080.).
引用
- Yoshida M, Takizawa K, Nonaka S, et al. Conventional versus traction-assisted endoscopic submucosal dissection for large esophageal cancers: a multicenter, randomized controlled trial (with video). Gastrointest Endosc. 2019. PMID: 31445039. doi:10.1016/j.gie.2019.08.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。